Loading clinical trials...
Loading clinical trials...
A Phase 2, Open-Label, Single-Arm Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Conditions
Interventions
INCB054707
Locations
4
United States
Investigative Site
Los Angeles, California, United States
Investigative Site
Tampa, Florida, United States
Investigative Site
New York, New York, United States
Investigative Site
Hershey, Pennsylvania, United States
Start Date
July 17, 2018
Primary Completion Date
April 22, 2019
Completion Date
April 22, 2019
Last Updated
September 26, 2022
NCT06958211
NCT06921850
NCT05889182
NCT05243966
NCT06993233
NCT06888193
Lead Sponsor
Incyte Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions